Pharmaceutical composition containing disrupted cell suspension of monilia albicans and euglobulin, and method of treating aniamls infected with canine distemper virus or animals having neurological disorders by using the same

摘要

Monilriah albedo kaenseu (monilia albicans) discloses a pharmaceutical composition and method of treating neurological diseases and animal visible animals infected with dog distemper virus strain using the same liquid and the reason globulin (euglobulin) as an active ingredient. The pharmaceutical according to the present inventive composition comprises a liquid and the strain monilriah albedo kaenseu reason globulin as an effective component, the albedo monilriah kaenseu strain reason globulin solution 10 mg to 250 mg per 1 ㎖ this is contained. The pharmaceutical compositions according to the present invention shows a superior effect in the treatment of animals showing neurological disorders, as well as animals infected with dog distemper virus. ; Dogs, distemper, monilriah Albi kaenseu